Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02128139Completed

Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study

Role: collaborator

NCT06302933Not ApplicableRecruiting

Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

Role: collaborator

NCT02043418Active Not Recruiting

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

Role: collaborator

NCT02742467Phase 4Completed

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

Role: collaborator

NCT02570334Not ApplicableUnknown

A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)

Role: collaborator

All 5 trials loaded